IL6 and systemic sclerosis: In other studies, IL1β and IL13 have also been recorded to be significantly elevated in the serum and plasma of lcSSc patients with PAH [32,149], while IL6 levels, even if not significantly different between SSc and controls, were found to be lower in patients with DUs compared to those without [150].